GMV The Future, page-590

I like your thinking Glyco.
My reading of the 4C commentary is the GBP 256k pa was for the 7 accounts and the 3 trial sites are for a separate and additional private hospital group with no amount nominated. Everyone is free to guess what that amount is.
My guess is that we will see more news on UK (probably signed contracts) soon. I’ve noticed a trend in the 4C commentary, that Yacov tends write his topics in the order that he wants to grab the attention of investors, i.e start with UK news, then new provider agreements, then growing revenue from IDTFs services, Hygea, etc and lastly the MOUs. To me this gives an indication of what news will be material to the business in the near term, medium term and longer term.